Alzamend Neuro Inc (ALZN) financials · $2.4M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Alzamend Neuro Inc (ALZN) $2.4M cap.
| Line | FY2026 | FY2025 |
|---|---|---|
| Operating Income | -$8.77M | -$4.50M |
| Net Income | -$8.77M | -$4.51M |
| EPS (Diluted) | -$2.63 | -$11.32 |
| Line | FY2026 | FY2025 |
|---|---|---|
| Total Assets | $2.08M | $4.60M |
| Current Assets | $1.76M | $4.18M |
| Cash & Equivalents | $710.7K | $3.95M |
| PP&E | $314.9K | $425.6K |
| Total Liabilities | $1.35M | $634.8K |
| Shareholders' Equity | $733.2K | $3.97M |
| Retained Earnings | -$67.3M | -$58.5M |
| Line | FY2026 | FY2025 |
|---|---|---|
| Operating Cash Flow | -$8.07M | -$6.57M |
| Investing Cash Flow | N/A | -$300.0K |
| Financing Cash Flow | $4.83M | $10.4M |
FAQ
What is ALZN P/E and revenue?
Alzamend Neuro Inc (ALZN) $2.4M cap.
What is ALZN revenue?
ALZN income-statement cache has no revenue figure yet.
Is ALZN profitable?
Alzamend Neuro Inc last cached net income is -$8.77M (FY2026).
What are ALZN total assets?
Alzamend Neuro Inc last cached total assets are $2.08M (FY2026).
What is ALZN free cash flow?
No cached cash-flow row for ALZN yet.
Not investment advice. Cached statements, not a live tape.